Defining Th-cell subsets in a classical and tissue-specific manner: Examples from the skin

European Journal of Immunology

Volumn 44, Issue 12, 2014, Pages 3475-3483

  Eyerich, Stefanie ^a   Zielinski, Christina E ^b  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cytokine; Microenvironment; Skin; Th cells; Transcription factor

Indexed keywords

CYTOKINE;

ADAPTIVE IMMUNITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL HETEROGENEITY; CELL INTERACTION; CELL LINEAGE; CELL MIGRATION; CELL REGENERATION; CYTOKINE RELEASE; DERMATITIS; HELPER CELL; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE RECIRCULATION; LYMPHOID ORGAN; MICROENVIRONMENT; PHENOTYPIC VARIATION; PRIORITY JOURNAL; SHORT SURVEY; SKIN CELL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TISSUE SPECIFICITY; ANIMAL; ANTIBODY SPECIFICITY; CLASSIFICATION; IMMUNOLOGY; INFLAMMATION; PATHOLOGY; SKIN; SKIN DISEASE;

ANIMALS; CYTOKINES; HUMANS; INFLAMMATION; ORGAN SPECIFICITY; SKIN; SKIN DISEASES; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84924074940     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201444891     Document Type: Short Survey

References (77)

1. Mosmann, T. R. and Coffman, R. L., TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 1989. 7: 145-173.
2. Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L. et al., Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006. 441: 235-238.
3. Sallusto, F., Zielinski, C. E. and Lanzavecchia, A., Human Th17 subsets. Eur. J. Immunol. 2012. 42: 2215-2220.
4. Eyerich, S., Eyerich, K., Pennino, D., Carbone, T., Nasorri, F., Pallotta, S., Cianfarani, F. et al., Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J. Clin. Invest. 2009. 119: 3573-3585.
5. Duhen, T., Geiger, R., Jarrossay, D., Lanzavecchia, A. and Sallusto, F., Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat. Immunol. 2009. 10: 857-863.
6. Trifari, S., Kaplan, C. D., Tran, E. H., Crellin, N. K. and Spits, H., Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat. Immunol. 2009. 10: 864-871.
7. Veldhoen, M., Uyttenhove, C., van Snick, J., Helmby, H., Westendorf, A., Buer, J., Martin, B. et al., Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol. 2008. 9: 1341-1346.
8. Eyerich, K., Pennino, D., Scarponi, C., Foerster, S., Nasorri, F., Behrendt, H., Ring, J. et al., IL-17 in atopic eczema: linking allergen-specific adaptive andmicrobial-triggered innate immune response. J. Allergy Clin. Immunol. 2009. 123: 59-66, e4.
9. Annunziato, F., Cosmi, L., Santarlasci, V., Maggi, L., Liotta, F., Mazzinghi, B., Parente, E. et al., Phenotypic and functional features of human Th17 cells. J. Exp. Med. 2007. 204: 1849-1861.
10. Cosmi, L., Maggi, L., Santarlasci, V., Capone, M., Cardilicchia, E., Frosali, F., Querci, V. et al., Identification of a novel subset of human circulating memory CD4(+) T cells that produce both IL-17A and IL-4. J. Allergy Clin. Immunol. 2010. 125: 222-230, e1-e4.
11. Wang, Y., Godec, J., Ben-Aissa, K., Cui, K., Zhao, K., Pucsek, A. B., Lee, Y. K. et al., The transcription factors T-bet and Runx are required for the ontogeny of pathogenic interferon-gamma-producing T helper 17 cells. Immunity 2014. 40: 355-366.
12. Zielinski, C. E., Mele, F., Aschenbrenner, D., Jarrossay, D., Ronchi, F., Gattorno, M., Monticelli, S. et al., Pathogen-induced human TH17 cells produce IFN-gamma or IL-10 and are regulated by IL-1beta. Nature 2012. 484: 514-518.
13. Stockinger, B., Di Meglio, P., Gialitakis, M. and Duarte, J. H., The aryl hydrocarbon receptor: multitasking in the immune system. Annu. Rev. Immunol. 2014. 32: 403-432.
14. Prigent, L., Robineau, M., Jouneau, S., Morzadec, C., Louarn, L., Vernhet, L., Fardel, O. et al., The aryl hydrocarbon receptor is functionally upregulated early in the course of human T-cell activation. Eur. J. Immunol. 2014. 44: 1330-1340.
15. Roncarolo, M. G. and Gregori, S., Is FOXP3 a bona fide marker for human regulatory T cells? Eur. J. Immunol. 2008. 38: 925-927.
16. Huehn, J., Polansky, J. K. and Hamann, A., Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage? Nat. Rev. Immunol. 2009. 9: 83-89.
17. Bending, D., Newland, S., Krejci, A., Phillips, J. M., Bray, S. and Cooke, A., Epigenetic changes at Il12rb2 and Tbx21 in relation to plasticity behavior of Th17 cells. J. Immunol. 2011. 186: 3373-3382.
18. Vahedi, G., Kanno, Y., Sartorelli, V. and O'Shea, J. J., Transcription factors and CD4 T cells seeking identity: masters, minions, setters and spikers. Immunology 2013. 139: 294-298.
19. Vahedi, G., Poholek, A., Hand, T. W., Laurence, A., Kanno, Y., O'Shea, J. J. and Hirahara, K., Helper T-cell identity and evolution of differential transcriptomes and epigenomes. Immunol. Rev. 2013. 252: 24-40.
20. Vahedi, G., Takahashi, H., Nakayamada, S., Sun, H. W., Sartorelli, V., Kanno, Y. and O'Shea, J. J., STATs shape the active enhancer landscape of T cell populations. Cell 2012. 151: 981-993.
21. Ciofani, M., Madar, A., Galan, C., Sellars, M., Mace, K., Pauli, F., Agarwal, A. et al., A validated regulatory network for Th17 cell specification. Cell 2012. 151: 289-303.
22. Samstein, R. M., Arvey, A., Josefowicz, S. Z., Peng, X., Reynolds, A., Sandstrom, R., Neph, S. et al., Foxp3 exploits a pre-existent enhancer landscape for regulatory T cell lineage specification. Cell 2012. 151: 153-166.
23. Mahnke, Y. D., Brodie, T. M., Sallusto, F., Roederer, M. and Lugli, E., The who's who of T-cell differentiation: human memory T-cell subsets. Eur. J. Immunol. 2013. 43: 2797-2809.
24. Sallusto, F., Lenig, D., Forster, R., Lipp, M. and Lanzavecchia, A., Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999. 401: 708-712.
25. Clark, R. A., Watanabe, R., Teague, J. E., Schlapbach, C., Tawa, M. C., Adams, N., Dorosario, A. A. et al., Skin effector memory T cells do not recirculate and provide immune protection in alemtuzumab-treated CTCL patients. Sci. Transl. Med. 2012. 4: 117ra117.
26. + tissue-resident memory T cells of skin. Nat. Immunol. 2013. 14: 1294-1301.
27. Xia, M., Hu, S., Fu, Y., Jin, W., Yi, Q., Matsui, Y., Yang, J. et al., CCR10 regulates balancedmaintenance and function of resident regulatory and effector T cells to promote immune homeostasis in the skin. J. Allergy Clin. Immunol. 2014. 134: 634-644.
28. Jiang, X., Clark, R. A., Liu, L., Wagers, A. J., Fuhlbrigge, R. C. and Kupper, T. S., Skin infection generates non-migratory memory CD8+ T(RM) cells providing global skin immunity. Nature 2012. 483: 227-231.
29. Acosta-Rodriguez, E. V., Rivino, L., Geginat, J., Jarrossay, D., Gattorno, M., Lanzavecchia, A., Sallusto, F. et al., Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 2007. 8: 639-646.
30. Noster, R., Riedel, R., Mashregi, M.-F., Radbruch, H., Harms, L., Haftmann, C., Chang, H.-D. et al., IL-17 and GM-CSF expression are antagonistically regulated by human T helper cells. Sci. Transl. Med. 2014. 6: 241ra80.
31. Clark, R. A., Chong, B., Mirchandani, N., Brinster, N. K., Yamanaka, K., Dowgiert, R. K. and Kupper, T. S., The vast majority of CLA+ T cells are resident in normal skin. J. Immunol. 2006. 176: 4431-4439.
32. Turner, D. L., Gordon, C. L. and Farber, D. L., Tissue-resident T cells, in situ immunity and transplantation. Immunol. Rev. 2014. 258: 150-166.
33. Shin, H. and Iwasaki, A., Tissue-resident memory T cells. Immunol. Rev. 2013. 255: 165-181.
34. Mora, J. R. and von Andrian, U. H., T-cell homing specificity and plasticity: new concepts and future challenges. Trends Immunol. 2006. 27: 235-243.
35. Wang, X., Fujita, M., Prado, R., Tousson, A., Hsu, H. C., Schottelius, A., Kelly, D. R. et al., Visualizing CD4 T-cell migration into inflamed skin and its inhibition by CCR4/CCR10 blockades using in vivo imaging model. Br. J. Dermatol. 2010. 162: 487-496.
36. Pennino, D., Eyerich, K., Scarponi, C., Carbone, T., Eyerich, S., Nasorri, F., Garcovich, S. et al., IL-17 amplifies human contact hypersensitivity by licensing hapten nonspecific Th1 cells to kill autologous keratinocytes. J. Immunol. 2010. 184: 4880-4888.
37. + T lymphocytes in the absence of professional antigen-presenting cells. J. Invest. Dermatol. 2002. 118: 172-179.
38. Gamerdinger, K., Moulon, C., Karp, D. R., Van Bergen, J., Koning, F., Wild, D., Pflugfelder, U. et al., Anew type ofmetal recognition by human T cells: contact residues for peptide-independent bridging of T cell receptor and major histocompatibility complex by nickel. J. Exp. Med. 2003. 197: 1345-1353.
39. Li, H., Llera, A., Malchiodi, E. L. and Mariuzza, R. A., The structural basis of T cell activation by superantigens. Annu. Rev. Immunol. 1999. 17: 435-466.
40. Niebuhr, M., Scharonow, H., Gathmann, M., Mamerow, D. and Werfel, T., Staphylococcal exotoxins are strong inducers of IL-22: a potential role in atopic dermatitis. J. Allergy Clin. Immunol. 2010. 126: 1176-1183 e1174.
41. Mempel, M., Lina, G., Hojka, M., Schnopp, C., Seidl, H. P., Schafer, T., Ring, J. et al., High prevalence of superantigens associated with the egc locus in Staphylococcus aureus isolates from patients with atopic eczema. Eur. J. Clin. Microbiol. Infect. Dis. 2003. 22: 306-309.
42. Miller, M., Cook, H. A., Furuya, E. Y., Bhat, M., Lee, M. H., Vavagiakis, P., Visintainer, P. et al., Staphylococcus aureus in the community: colonization versus infection. PLoS One 2009. 4: e6708.
43. Eyerich, S., Eyerich, K., Cavani, A. and Schmidt-Weber, C., IL-17 and IL-22: siblings, not twins. Trends Immunol. 2010. 31: 354-361.
44. Tang, T. S., Bieber, T. and Williams, H. C., Does "autoreactivity" play a role in atopic dermatitis? J. Allergy Clin. Immunol. 2012. 129: 1209-1215 e1202.
45. Lande, R., Ganguly, D., Facchinetti, V., Frasca, L., Conrad, C., Gregorio, J., Meller, S. et al., Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci. Transl. Med. 2011. 3: 73ra19.
46. Nishimoto, S., Kotani, H., Tsuruta, S., Shimizu, N., Ito, M., Shichita, T., Morita, R. et al., Th17 cells carrying TCR recognizing epidermal autoantigen induce psoriasis-like skin inflammation. J. Immunol. 2013. 191: 3065-3072.
47. Howell, M. D., Boguniewicz, M., Pastore, S., Novak, N., Bieber, T., Girolomoni, G. and Leung, D. Y., Mechanism of HBD-3 deficiency in atopic dermatitis. Clin. Immunol. 2006. 121: 332-338.
48. Wolk, K., Witte, K., Witte, E., Raftery, M., Kokolakis, G., Philipp, S., Schonrich, G. et al., IL-29 is produced by T(H)17 cells and mediates the cutaneous antiviral competence in psoriasis. Sci. Transl. Med. 2013. 5: 204ra129.
49. Quaranta, M., Knapp, B., Garzorz, N., Mattii, M., Pullabhatla, V., Pennino, D., Andres, C. et al., Intra-individual genome expression analysis reveals a specific molecular signature of psoriasis and eczema. Sci. Transl. Med. 2014. 6: 244ra90.
50. Eyerich, S., Onken, A. T., Weidinger, S., Franke, A., Nasorri, F., Pennino, D., Grosber, M. et al., Mutual antagonism of T cells causing psoriasis and atopic eczema. N. Engl. J. Med. 2011. 365: 231-238.
51. Liang, S. C., Tan, X. Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M. and Fouser, L. A., Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 2006. 203: 2271-2279.
52. Eyerich, S., Wagener, J., Wenzel, V., Scarponi, C., Pennino, D., Albanesi, C., Schaller, M. et al., IL-22 and TNF-alpha represent a key cytokine combination for epidermal integrity during infection with Candida albicans. Eur. J. Immunol. 2011. 41: 1894-1901.
53. Zheng, Y., Danilenko, D. M., Valdez, P., Kasman, I., Eastham-Anderson, J., Wu, J. and Ouyang, W., Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007. 445: 648-651.
54. Sarra, M., Caruso, R., Cupi, M. L., Monteleone, I., Stolfi, C., Campione, E., Diluvio, L. et al., IL-21 promotes skin recruitment of CD4(+) cells and drives IFN-gamma-dependent epidermal hyperplasia. J. Immunol. 2011. 186: 5435-5442.
55. Nestle, F. O., Kaplan, D. H. and Barker, J., Psoriasis. N. Engl. J. Med. 2009. 361: 496-509.
56. Ghoreschi, K., Thomas, P., Breit, S., Dugas, M., Mailhammer, R., van Eden, W., van der Zee, R. et al., Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease. Nat. Med. 2003. 9: 40-46.
57. Eyerich, K. and Novak, N., Immunology of atopic eczema: overcoming the Th1/Th2 paradigm. Allergy 2013. 68: 974-982.
58. Albanesi, C., Fairchild, H. R., Madonna, S., Scarponi, C., De Pita, O., Leung, D. Y. and Howell, M. D., IL-4 and IL-13 negatively regulate TNF-alpha-and IFN-gamma-induced beta-defensin expression through STAT-6, suppressor of cytokine signaling (SOCS)-1, and SOCS-3. J. Immunol. 2007. 179: 984-992.
59. Bieber, T., Atopic dermatitis. N. Engl. J. Med. 2008. 358: 1483-1494.
60. Howell, M. D., Fairchild, H. R., Kim, B. E., Bin, L., Boguniewicz, M., Redzic, J. S., Hansen, K. C. et al., Th2 cytokines act on S100/A11 to downregulate keratinocyte differentiation. J. Invest. Dermatol. 2008. 128: 2248-2258.
61. Howell, M. D., Kim, B. E., Gao, P., Grant, A. V., Boguniewicz, M., DeBenedetto, A., Schneider, L. et al., Cytokine modulation of atopic dermatitis filaggrin skin expression. J. Allergy Clin. Immunol. 2009. 124: R7-R12.
62. Kim, B. E., Leung, D. Y., Boguniewicz, M. and Howell, M. D., Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6. Clin. Immunol. 2008. 126: 332-337.
63. Schwarz, T., No eczema without keratinocyte death. J. Clin. Invest. 2000. 106: 9-10.
64. + T cell subsets against keratinocytes. J. Immunol. 2000. 165: 3058-3064.
65. O'Garra, A., Stockinger, B. and Veldhoen, M., Differentiation of human T(H)-17 cells does require TGF-beta! Nat. Immunol. 2008. 9: 588-590.
66. LeibundGut-Landmann, S., Gross, O., Robinson, M. J., Osorio, F., Slack, E. C., Tsoni, S. V., Schweighoffer, E. et al., Syk-and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat. Immunol. 2007. 8: 630-638.
67. McGeachy, M. J. and McSorley, S. J., Microbial-induced Th17: superhero or supervillain? J. Immunol. 2012. 189: 3285-3291.
68. Zielinski, C. E., Regulation of proinflammatory and anti-inflammatory Th17 cells. Z Rheumatol. 2013. 72: 457-461.
69. Eyerich, K., Eyerich, S., Hiller, J., Behrendt, H. and Traidl-Hoffmann, C., Chronic mucocutaneous candidiasis, from bench to bedside. Eur. J. Dermatol. 2010. 20: 260-265.
70. Glocker, E. O., Hennigs, A., Nabavi, M., Schaffer, A. A., Woellner, C., Salzer, U., Pfeifer, D. et al., A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N. Engl. J. Med. 2009. 361: 1727-1735.
71. Liu, L., Okada, S., Kong, X. F., Kreins, A. Y., Cypowyj, S., Abhyankar, A., Toubiana, J. et al., Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J. Exp. Med. 2011. 208: 1635-1648.
72. Eyerich, K., Foerster, S., Rombold, S., Seidl, H. P., Behrendt, H., Hofmann, H., Ring, J. et al., Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22. J. Invest. Dermatol. 2008. 128: 2640-2645.
73. Puel, A., Cypowyj, S., Bustamante, J., Wright, J. F., Liu, L., Lim, H. K., Migaud, M. et al., Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science 2011. 332: 65-68.
74. Puel, A., Doffinger, R., Natividad, A., Chrabieh, M., Barcenas-Morales, G., Picard, C., Cobat, A. et al., Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J. Exp. Med. 2010. 207: 291-297.
75. Langley, R. G., Elewski, B. E., Lebwohl, M., Reich, K., Griffiths, C. E., Papp, K., Puig, L. et al., Secukinumab in plaque psoriasis-results of two phase 3 trials. N. Engl. J. Med. 2014. 371: 326-338.
76. Griffiths, C. E., Strober, B. E., van de Kerkhof, P., Ho, V., Fidelus-Gort, R., Yeilding, N., Guzzo, C. et al., Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis. N. Engl. J. Med. 2010. 362: 118-128.
77. Littman, D. R. and Pamer, E. G., Role of the commensal microbiota in normal and pathogenic host immune responses. Cell Host Microbe 2011. 10: 311-323.